[HTML][HTML] Remdesivir and its antiviral activity against COVID-19: A systematic review

A Frediansyah, F Nainu, K Dhama, M Mudatsir… - … epidemiology and global …, 2021 - Elsevier
Background To summarize the antiviral activities of remdesivir against SARS-CoV-2, the
causative agent of COVID-19. Methods Available publications were systematically explored …

[HTML][HTML] Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

H Kaur, N Shekhar, S Sharma, P Sarma… - Pharmacological …, 2021 - Springer
Introduction COVID-19 cases are on surge; however, there is no efficient treatment or
vaccine that can be used for its management. Numerous clinical trials are being reviewed for …

[HTML][HTML] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk, RA Çetinkaya, R Güner… - BMC infectious …, 2021 - Springer
Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …

Safety and effectiveness of azithromycin in patients with COVID-19: an open-label randomised trial

E Sekhavati, F Jafari, SA SeyedAlinaghi… - International journal of …, 2020 - Elsevier
As no specific pharmacological treatment has been validated for use in coronavirus disease
2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these …

[HTML][HTML] Impacto del confinamiento por COVID-19 en la calidad de vida y salud mental

CL Ballena, L Cabrejos, Y Davila… - Revista del Cuerpo …, 2021 - scielo.org.pe
Introducción: La pandemia por SARS-Cov-2 ha tenido un impacto negativo en múltiples
aspectos de la vida humana, tanto en lo físico, psicológico, económico, social y cultural. Las …

Corona viruses: a review on SARS, MERS and COVID-19

NN Chathappady House, S Palissery… - Microbiology …, 2021 - journals.sagepub.com
After the outbreak of SARS and MERS, the world is now in the grip of another viral disease
named COVID-19 caused by a beta Coronavirus–SARS COV-2 which appears to be the …

Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis: Ivermectin in COVID-19: A meta-analysis

BM Padhy, RR Mohanty, S Das… - Journal of Pharmacy …, 2020 - journals.library.ualberta.ca
The current management of COVID-19 is mostly limited to general supportive care and
symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for …

[HTML][HTML] Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in primary healthcare centers in Dubai: a cross-sectional survey, 2020

AH Albahri, SA Alnaqbi, SA Alnaqbi… - Frontiers in Public …, 2021 - frontiersin.org
Introduction: The coronavirus disease 2019 (COVID-19) pandemic continues to challenge
healthcare services worldwide. Healthcare workers (HCWs) are key to the continued effort to …

[HTML][HTML] Repurposing of antibiotics for clinical management of COVID-19: a narrative review

A Yacouba, A Olowo-Okere, I Yunusa - Annals of Clinical Microbiology …, 2021 - Springer
Background Drug repurposing otherwise known as drug repositioning or drug re-profiling is
a time-tested approach in drug discovery through which new medical uses are being …

[PDF][PDF] A case series of 100 COVID-19 positive patients treated with combination of ivermectin and doxycycline

MT Alam, R Murshed, E Bhiuyan, S Saber… - Journal of Bangladesh …, 2020 - academia.edu
Background: A definitive treatment of SARS CoV-2 is yet to arrive and the human death toll
rises exponentially globally. In this health emergency, it might be useful to look into the old …